RT Conference Proceedings
T1 Phase III CLEAR trial in advanced renal cell carcinoma (aRCC): Outcomes in subgroups and toxicity update
A1 Choueiri, T. K.
A1 Eto, M.
A1 Kopyltsov, E.
A1 Rha, S. Y.
A1 Porta, C. G.
A1 Motzer, R.
A1 Gruenwald, V.
A1 Hutson, T. E.
A1 Mendez-Vidal, M. J.
A1 Hong, S-H.
A1 Winquist, E.
A1 Goh, J. C. H.
A1 Maroto, P.
A1 Buchler, T.
A1 Takagi, T.
A1 Rodriguez-Lopez, K.
A1 Xing, D.
A1 Smith, A. D.
A1 Powles, T.
PB Elsevier
SN 0923-7534
YR 2021
FD 2021-09-21
LK https://hdl.handle.net/10668/25497
UL https://hdl.handle.net/10668/25497
LA en
DS RISalud
RD Apr 17, 2025